English
简体中文
Total: £ 56.28
2026-01-20 | Pages: 140 | Tables: 139
The global Tongbianling Jiaonang market was valued at US$ 52.05 million in 2025 and is anticipated to reach US$ 74.44 million by 2032, at a CAGR of 5.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global ec...
2026-01-20 | Pages: 134 | Tables: 137
The global Crotamiton Cream market was valued at US$ 34.97 million in 2025 and is anticipated to reach US$ 45.75 million by 2032, at a CAGR of 4.0% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-01-20 | Pages: 102 | Tables: 93
The global Ornidazole Capsules market was valued at US$ 11.4 million in 2025 and is anticipated to reach US$ 15.23 million by 2032, at a CAGR of 4.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-01-20 | Pages: 109 | Tables: 112
The global Dextromethorphan Hydrobromide Syrups market was valued at US$ 17.41 million in 2025 and is anticipated to reach US$ 23.17 million by 2032, at a CAGR of 4.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty int...
2026-01-20 | Pages: 121 | Tables: 118
The global Menadiol Diacetate Tablets market was valued at US$ 20.11 million in 2025 and is anticipated to reach US$ 25.75 million by 2032, at a CAGR of 3.7% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glob...
2026-01-20 | Pages: 122 | Tables: 123
The global Sulfacetamide Sodium Eye Drops market was valued at US$ 34.54 million in 2025 and is anticipated to reach US$ 47.17 million by 2032, at a CAGR of 4.6% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the ...
2026-01-20 | Pages: 141 | Tables: 139
The global Sulfamethoxazole Sulfadiazine and Trimethoprim Tablets market was valued at US$ 49.95 million in 2025 and is anticipated to reach US$ 65.96 million by 2032, at a CAGR of 4.1% from 2026 to 2032.The 2025 U.S. tariff policies introduce profou...
2026-01-20 | Pages: 122 | Tables: 125
The global Ethyl Polyenoate Soft Capsule market was valued at US$ 40.95 million in 2025 and is anticipated to reach US$ 54.79 million by 2032, at a CAGR of 4.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the g...
2026-01-20 | Pages: 111 | Tables: 109
The global Combined Polio Vaccine market was valued at US$ 312 million in 2025 and is anticipated to reach US$ 443 million by 2032, at a CAGR of 5.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-01-20 | Pages: 110 | Tables: 115
The global Hyperuricemia Micromolecular Drugs market was valued at US$ 3164 million in 2025 and is anticipated to reach US$ 5628 million by 2032, at a CAGR of 8.7% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into th...
2026-01-20 | Pages: 108 | Tables: 110
The global Tiapride Hydrochloride Tablets market was valued at US$ 170 million in 2025 and is anticipated to reach US$ 224 million by 2032, at a CAGR of 4.1% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glob...
2026-01-20 | Pages: 117 | Tables: 117
The global Josamycin Tablets market was valued at US$ 132 million in 2025 and is anticipated to reach US$ 168 million by 2032, at a CAGR of 3.5% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic l...
2026-01-20 | Pages: 98 | Tables: 100
The global Duvelisib for Relapsed CLL/SLL market was valued at US$ 228 million in 2025 and is anticipated to reach US$ 571 million by 2032, at a CAGR of 14.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glo...
2026-01-20 | Pages: 108 | Tables: 112
The global Medical Liquid Embolic Agents market was valued at US$ 153 million in 2025 and is anticipated to reach US$ 253 million by 2032, at a CAGR of 7.6% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the globa...
2026-01-20 | Pages: 108 | Tables: 110
The global Non-Adhesive Liquid Embolic Agents market was valued at US$ 153 million in 2025 and is anticipated to reach US$ 253 million by 2032, at a CAGR of 7.6% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the ...
